These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10052901

  • 1. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis.
    Dalla Costa T, Nolting A, Kovar A, Derendorf H.
    J Antimicrob Chemother; 1998 Dec; 42(6):769-78. PubMed ID: 10052901
    [Abstract] [Full Text] [Related]

  • 2. Determination of free extracellular concentrations of piperacillin by microdialysis.
    Nolting A, Costa TD, Vistelle R, Rand KH, Derendorf H.
    J Pharm Sci; 1996 Apr; 85(4):369-72. PubMed ID: 8901070
    [Abstract] [Full Text] [Related]

  • 3. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
    Tomaselli F, Dittrich P, Maier A, Woltsche M, Matzi V, Pinter J, Nuhsbaumer S, Pinter H, Smolle J, Smolle-Jüttner FM.
    Br J Clin Pharmacol; 2003 Jun; 55(6):620-4. PubMed ID: 12814459
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam.
    Kim MK, Capitano B, Mattoes HM, Xuan D, Quintiliani R, Nightingale CH, Nicolau DP.
    Pharmacotherapy; 2002 May; 22(5):569-77. PubMed ID: 12013355
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    Varghese JM, Jarrett P, Boots RJ, Kirkpatrick CM, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
    Derendorf H, Dalla Costa T.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):482-8. PubMed ID: 8937930
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.
    Occhipinti DJ, Pendland SL, Schoonover LL, Rypins EB, Danziger LH, Rodvold KA.
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2511-7. PubMed ID: 9371358
    [Abstract] [Full Text] [Related]

  • 8. Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.
    Strenkoski-Nix LC, Forrest A, Schentag JJ, Nix DE.
    J Clin Pharmacol; 1998 Nov; 38(11):1063-71. PubMed ID: 9824789
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
    Sörgel F, Kinzig M.
    Eur J Surg Suppl; 1994 Nov; (573):39-44. PubMed ID: 7524794
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.
    Nau R, Kinzig-Schippers M, Sörgel F, Schinschke S, Rössing R, Müller C, Kolenda H, Prange HW.
    Antimicrob Agents Chemother; 1997 May; 41(5):987-91. PubMed ID: 9145857
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic characteristics of piperacillin/tazobactam.
    Sörgel F, Kinzig M.
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S14-20. PubMed ID: 7962984
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam.
    Kim MK, Xuan D, Quintiliani R, Nightingale CH, Nicolau DP.
    J Antimicrob Chemother; 2001 Aug; 48(2):259-67. PubMed ID: 11481298
    [Abstract] [Full Text] [Related]

  • 13. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
    Sörgel F, Kinzig M.
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():39-60. PubMed ID: 8383655
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.
    Wise R, Logan M, Cooper M, Andrews JM.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1081-4. PubMed ID: 1656853
    [Abstract] [Full Text] [Related]

  • 15. Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam.
    Lister PD, Prevan AM, Sanders CC.
    Antimicrob Agents Chemother; 1997 Apr; 41(4):721-7. PubMed ID: 9087477
    [Abstract] [Full Text] [Related]

  • 16. Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.
    Auclair B, Ducharme MP.
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1465-8. PubMed ID: 10348772
    [Abstract] [Full Text] [Related]

  • 17. Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.
    Incavo SJ, Ronchetti PJ, Choi JH, Wu H, Kinzig M, Sörgel F.
    Antimicrob Agents Chemother; 1994 Apr; 38(4):905-7. PubMed ID: 8031071
    [Abstract] [Full Text] [Related]

  • 18. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
    Nichols K, Chung EK, Knoderer CA, Buenger LE, Healy DP, Dees J, Crumby AS, Kays MB.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978
    [Abstract] [Full Text] [Related]

  • 19. Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
    Dowell JA, Korth-Bradley J, Milisci M, Tantillo K, Amorusi P, Tse S.
    J Clin Pharmacol; 2001 Sep; 41(9):979-86. PubMed ID: 11549103
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.
    Bourget P, Lesne-Hulin A, Le Reveillé R, Le Bever H, Carsin H.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):139-45. PubMed ID: 8787895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.